What we've found so far is that the kidneys appear to be the main organ affected by high levels of sodium ferrocyanide, and in rat studies, doses up to 4.4 mg per kg of body weight per day did not cause lasting harm [1]. This amount represents the highest dose tested without observed adverse effects over the study period, which we use as an indicator of the no-observed-adverse-effect level (NOAEL) based on the available data.
Our analysis of the evidence shows that when rats were exposed to sodium ferrocyanide, the kidneys showed small, temporary changes at certain doses, but these effects did not persist [1]. The dose of 4.4 mg/kg/day was the highest at which no lasting harm was seen, suggesting this may be a safe threshold in these animal studies [1]. However, we do not have data on long-term exposure or effects in humans, so we cannot assume the same threshold applies to people.
The evidence we've reviewed leans toward the kidneys being the primary organ impacted, but the changes observed were mild and reversible at the NOAEL [1]. We have not found any studies that refute this, but the total number of studies is very limited—only one assertion based on animal research.
Because our current analysis relies entirely on animal data, we cannot say how this translates to human health. We also do not know if other organs could be affected at higher doses or over longer periods. What we’ve found so far is based on short-term exposure in rats, and more research would be needed to understand broader implications.
Practical takeaway: In lab studies, sodium ferrocyanide didn’t cause lasting harm in rats at doses up to 4.4 mg per kg of body weight, and the kidneys were the main organ showing any response—even if temporary. Until we have more data, especially in humans, we can’t say what this means for everyday exposure.
2 items of evidenceView full answer